CRISPR Therapeutics AG (CRSP)
USD 41.06
(-8.0%)
USD 41.06
(-8.0%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | -260.37 Million | -495.74 Million | 538.97 Million | -238.36 Million | 56.67 Million | -96.23 Million |
| Net Income | -153.61 Million | -650.17 Million | 377.66 Million | -348.86 Million | 66.85 Million | -164.98 Million |
| Depreciation & Amortization | 19.83 Million | 24.17 Million | 17.95 Million | 9.18 Million | 4.72 Million | 3.51 Million |
| Deferred income taxes | - | - | - | - | - | 4.27 Million |
| Stock-based compensation | 81.02 Million | 97.94 Million | 102.39 Million | 66.01 Million | 44.05 Million | 34.98 Million |
| Change in working capital | -193.58 Million | 19.84 Million | 26.85 Million | 33.44 Million | -48.43 Million | 10.55 Million |
| Other non-cash items | -14.04 Million | 12.47 Million | 14.1 Million | 1.85 Million | -10.53 Million | 15.41 Million |
| Investing Cash Flow | 374.64 Million | -258.65 Million | -1.03 Billion | -541.17 Million | 1.32 Million | -2.77 Million |
| Investments in PPE | -11.97 Million | -37.18 Million | -81.7 Million | -18.35 Million | -6.68 Million | -2.77 Million |
| Acquisitions | 2.5 Million | 221.46 Million | 953.72 Million | 522.81 Million | 8 Million | - |
| Investment purchases | -1.06 Billion | -1.41 Billion | -1.5 Billion | -593.99 Million | - | - |
| Sales/Maturities of investments | 1.45 Billion | 1.19 Billion | 555.6 Million | 71.18 Million | - | - |
| Other Investing Activities | -2.5 Million | -221.46 Million | -953.72 Million | -522.81 Million | 8 Million | - |
| Financing Cash Flow | 62.66 Million | 38.59 Million | 250.94 Million | 1.01 Billion | 430.98 Million | 315.93 Million |
| Debt repayment | - | - | - | - | - | - |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - | -57 Thousand |
| Common Stock Issuance | 32.72 Million | 38.59 Million | 250.94 Million | 982.28 Million | 415.01 Million | 307.05 Million |
| Other Financing Activities | 29.94 Million | 38.59 Million | 250.94 Million | 33.86 Million | 15.96 Million | 8.93 Million |
| Accounts receivables | -200 Million | 305 Thousand | -161 Thousand | -45 Thousand | -11 Thousand | 2.53 Million |
| Accounts payables | -20.24 Million | 5.16 Million | 37.51 Million | 25.74 Million | 5.02 Million | -323.28 Million |
| Inventory | 23.32 Million | - | -37.51 Million | -25.74 Million | -5.02 Million | 332.29 Million |
| Other working capital | 3.33 Million | 14.37 Million | 27.02 Million | 33.48 Million | -48.41 Million | -1 Million |
| Cash at beginning of period | 224.06 Million | 939.94 Million | 1.18 Billion | 948.81 Million | 459.81 Million | 242.91 Million |
| Cash at end of period | 401.06 Million | 224.06 Million | 939.94 Million | 1.18 Billion | 948.81 Million | 459.81 Million |
| Capital Expenditure | -11.97 Million | -37.18 Million | -81.7 Million | -18.35 Million | -6.68 Million | -2.77 Million |
| Effect of forex changes on cash | 73 Thousand | -80 Thousand | -11 Thousand | 40 Thousand | 15 Thousand | -22 Thousand |
| Net cash flow / Change in cash | 177 Million | -715.88 Million | -245.52 Million | 236.65 Million | 489 Million | 216.9 Million |
| Free Cash Flow | -272.34 Million | -532.92 Million | 457.26 Million | -256.72 Million | 49.99 Million | -99.01 Million |
| Breakdown | 2024 Q3 | 2024 Q2 | 2024 Q1 | 2023 FY | 2023 Q4 | 2023 Q3 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | -85.94 Million | -126.4 Million | -116.59 Million | -153.61 Million | 89.34 Million | -112.15 Million |
| Depreciation & Amortization | 4.73 Million | 4.84 Million | 4.83 Million | 19.83 Million | 4.9 Million | 4.92 Million |
| Deferred income taxes | - | - | - | - | - | - |
| Stock-based compensation | 21.54 Million | 23.67 Million | 19.4 Million | 81.02 Million | 18.42 Million | 19.96 Million |
| Change in working capital | -220.98 Million | 10.49 Million | 210.49 Million | -193.58 Million | -203.97 Million | 52.56 Million |
| Other non-cash items | 173.72 Million | 15.9 Million | -188.75 Million | -14.04 Million | -4.76 Million | -5.15 Million |
| Investing Cash Flow | -161.6 Million | -126.9 Million | -97.8 Million | 374.64 Million | -81.45 Million | 121.34 Million |
| Investments in PPE | -219 Thousand | -707 Thousand | -721 Thousand | -11.97 Million | -738 Thousand | -2.11 Million |
| Acquisitions | - | - | - | 2.5 Million | 80.71 Million | - |
| Investment purchases | -388.67 Million | -475.97 Million | -334.41 Million | -1.06 Billion | -368.14 Million | -245.39 Million |
| Sales/Maturities of investments | 247.67 Million | 349.78 Million | 237.33 Million | 1.45 Billion | 287.43 Million | 369.86 Million |
| Other Investing Activities | -20.38 Million | -126.19 Million | -7.5 Million | -2.5 Million | -80.71 Million | -1 Million |
| Financing Cash Flow | 9.64 Million | -466 Thousand | 305.93 Million | 62.66 Million | 38.93 Million | 1.55 Million |
| Debt repayment | - | - | - | - | - | - |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | 466 Thousand | -466 Thousand | - | - | - | - |
| Common Stock Issuance | -305.46 Million | -466 Thousand | 305.93 Million | 32.72 Million | 32.72 Million | 1.55 Million |
| Other Financing Activities | 314.64 Million | 546 Thousand | 305.93 Million | 29.94 Million | 6.21 Million | 1.55 Million |
| Accounts receivables | - | - | 200 Million | -200 Million | -200 Million | 70 Million |
| Accounts payables | -38.15 Million | 9.28 Million | 9.44 Million | -20.24 Million | -9.19 Million | -24.69 Million |
| Inventory | - | - | - | 23.32 Million | 9.19 Million | 24.69 Million |
| Other working capital | -2.25 Million | 1.2 Million | 1.04 Million | 3.33 Million | -3.97 Million | -17.43 Million |
| Cash at beginning of period | 484.47 Million | 707.42 Million | 389.47 Million | 224.06 Million | 539.59 Million | 456.59 Million |
| Cash at end of period | 237.19 Million | 484.47 Million | 707.42 Million | 401.06 Million | 401.06 Million | 539.59 Million |
| Capital Expenditure | -219 Thousand | -707 Thousand | -721 Thousand | -11.97 Million | -738 Thousand | -2.11 Million |
| Effect of forex changes on cash | 75 Thousand | 2000.00 | -11 Thousand | 73 Thousand | 61 Thousand | -48 Thousand |
| Net cash flow / Change in cash | -247.28 Million | -222.95 Million | 317.95 Million | 177 Million | -138.52 Million | 83 Million |
| Free Cash Flow | -107.13 Million | -96.28 Million | 109.03 Million | -272.34 Million | -96.81 Million | -41.97 Million |
KSRYY
DX-PC
BTSG
GANECOS
3077
9272